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Abstract
The identification strategy of using expected date of birth to define treatment used
by Persson and Rossin-Slater (2016) to estimate the causal effect of in utero exposure to
stress on later outcomes has two potential flaws. First, the endogeneity of actual birth
date may make little practical difference. Second, there is likely greater measurement
error of gestation age in the treatment group. The conclusion that the authors are
the first to obtain a causal estimates in this context would be more credible had these
issues been addressed.
1 Introduction
In their paper “Family Ruptures, Stress, and the Mental Health of the Next Generation”,
Persson and Rossin-Slater attempt to estimate the causal effect of in utero exposure to
stress and mental health outcomes later in life. They do this by considering mothers who
experience the loss of a close relative during pregnancy as the treatment group. The control
group is mothers who experience this loss shortly after birth. Let c denote conception, b
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denote birth, and eb denote expected date of birth (eb = c + 280 days). Then the authors
estimate the causal effect using the following equation (equation 5 in the paper):
Outcome = β0 + β11[c ≤ RelativeDeath < eb] + , (1)
where the estimation sample is limited to mothers who experience the relative death during
pregnancy or within one year of birth. The concern with defining the treatment variable
as the relative death occurring prior to the actual date of birth is that the actual date of
birth may be correlated with the error term. On the one hand, there is the mechanical
relationship that a relative death is more likely to occur during pregnancy the longer the
pregnancy lasts. Also, there is the concern that the treatment defined using actual date of
birth is endogenous since relative death can affect the length of the pregnancy. The authors
claim that defining the treatment group based on the expected date of birth corrects for the
endogeneity. Alternatively, the causal parameter could be estimated using treatment based
on expected date of birth as an instrument for treatment based on actual date of birth.
It should be noted that variations of this identification strategy have been used previously
and that the objections raised apply to those papers as well (see Black et al. (2016); Currie
and Rossin-Slater (2013); Rossin-Slater (2013)). What follows is an exposition of the two
main concerns, and this note concludes with at brief remark.
2 Endogeneity of Actual Date of Birth Examined
As applied economists, we are trained to accept the pervasiveness of endogeneity. Any
claim that X is exogenous is treated with skepticism, while a claim that X is endogenous is
usually accepted without question. In this context, the authors claim that the regression of
the outcome on the endogenous X (treatment based on actual birth date) does not yield a
causal estimate, while the regression of the outcome on the exogenous Z (treatment based
on expected birth) does. The two stage least squared estimate of the causal parameter using
treatment based on expected birth date as an instrument for treatment based on actual birth
date is:
βIV1 =
∂Y/∂X
∂X/∂Z
(2)
The denominator is the coefficient from the first stage regression. If the instrument perfectly
predicts the endogenous variable, the causal parameter simply becomes the OLS estimate
of Y on X. In this context endogeneity may not generate much bias in the OLS estimate
based on the results of the first stage regression (R2 of approximately 0.97, Table D-1) and
the statement that “the instrument (relative death before expected birth date) is different
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from the actual exposure variable (relative death before actual birth date) for only about 1
percent of the individuals in our data.”
In a related paper Black et al. (2016), present the results using the same identification
strategy on different data and outcomes. They report that the first stage R2 is very close
to one and that the OLS estimates and the 2SLS estimates are very similar when consid-
ering later in life outcomes, but they do find differences when considering birth outcomes.
Other studies, such as Currie and Rossin-Slater (2013) and Rossin-Slater (2013), in different
contexts but still looking at in utero effects of some treatment find that instrumenting for
treatment based on actual date of birth using expected date of birth does yield different
results. Those studies instrument for not only the endogeneity of pregnancy length but also
location change. This yields a lower first stage R2. None of the studies that use expected
date of birth to instrument for actual date of birth conduct statistical tests for endogeneity
of actual date of birth for the various outcomes. A coefficient that is statistically significant
under OLS but not statistically significant using 2SLS is not necessarily due to a correction
of bias as it could be due to the higher variance of 2SLS. Similarly, a coefficient that is
statistically significant using 2SLS may not be statistically different from a non-significant
OLS estimate.
For example, consider the results for the effect of a death during pregnancy on birth
weight in table 2 of Black et al. (2016). The naive OLS estimate is -8.081 with a standard
error of 5.857, which is not significantly different from zero. The IV estimate is -22.391 with
a standard error of 6.153, which is significant at the 5% level. This yields a Hausman test
statistic of over 50, which is strongly significant so the null hypothesis of treatment based on
actual birth date being exogenous can be rejected. The Hausman test assumes homoskedas-
ticity, but the authors could have easily performed a regression based test. Black et al.
(2016) are able to attribute the vast majority of the difference in coefficients to the mechan-
ical relationship between the length of pregnancy and the likelihood of a death occurring
during pregnancy. However, correcting for this mechanical relationship only appears to mat-
ter for birth outcomes (although not for all birth outcomes). For the long term outcomes, a
Hausman test is unable to reject the null hypothesis that treatment based on actual date of
birth is exogeneous.
Authors who use this identification strategy should be aware that the exogenous treat-
ment based on the expected date of birth almost perfectly predicts the treatment based on
actual date of birth and test for the endogeneity of treatment based on actual date of birth.
For some outcomes, the endogeneity of treatment based on actual date of birth does not
appear to be significant enough to affect the results. The good news for researchers is that
in these cases instrumentation is not necessary to generate an estimate of the causal effect.
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Persson and Rossin-Slater (2016) do not report the results from any tests for endogeneity
and do not report the OLS coefficients using actual date of birth to define the treatment.
Therefore, the reader is not able to evaluate whether endogeneity is a significant problem
in their context. This is particularly problematic given the focus on long term outcomes for
which the endogeneity of actual birth date may not matter.
3 Measurement Error of Gestation Age
The second concern is related to the use of gestation age to generate the exogenous treatment
variable based on the expected date of birth. The expected date of birth is defined as the
date of conception plus 280 days. The problem is that the date of conception is not known,
so the authors calculate it using the gestation age, which is reported in the data. Gestation
age is itself merely an estimate, so the conception age as calculated is measured with error.
This is not a problem for this identification strategy unless the nature of the measurement
error differs for the treatment and control group.
The initial estimate of conception date is 14 days after the start of the last menstrual cycle.
This estimate is later refined based on prenatal ultrasounds. If the estimated gestational
age based on the ultrasound is significantly different from that based on the last menstrual
cycle, then the ultrasound estimate is used as the preferred measure.1 Significantly, the
accuracy of the estimate of gestational age based on ultrasound decreases as the pregnancy
progresses. The most accurate estimate of gestational age is obtained from an ultrasound
at between 10-12 weeks. By the 24 week mark, the estimate based on the ultrasound is no
more precise than that based on last menstrual cycle (Verburg et al., 2008). The problem
for this identification strategy is that individuals in the treatment group may delay or skip
prenatal appointments if they coincide with the treatment (e.g., death of a close relative,
hurricane, etc.). Particularly if these missed appointments are early in the pregnancy, the
treatment group may have poorly estimated gestation ages relative to the control group.
Persson and Rossin-Slater (2016) find that mothers in the treatment group are less likely to
have adequate prenatal care which corresponds to approximately one missed prenatal exam
for mothers who lose a close relative. They claim that this difference in prenatal care is not
sufficient to explain the differences in outcomes, but it could affect the estimate of gestational
age.
Some of the results are consistent with the hypothesis that mothers in the treatment
group have poorly measured gestational ages. They find that the treatment is associated
with an increased probability of pre-term birth and an increased probability of c-sections
1See American College of Obstetricians and Gynecologists (2014) for details.
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(Table 2, Table A5). Since pregnancies that end in a c-section right censor some of the
birth outcomes, the higher rate of c-sections could explain the decrease in average birth
weight and size measurements. In a study comparing the dating of pregnancies using first
and second trimester ultrasounds from the same pregnancy, Thagaard et al. (2016) find that
dating based on second trimester ultrasounds leads to a significantly lower rate of post-
term pregnancies (2.9% versus 2.1%) and a significantly higher rate of pre-term pregnancies
(4.6% versus 5.4%).2 In Persson and Rossin-Slater (2016) the treatment group has a pre-
term rate of 5.34% versus a 4.69% rate for the control group (Table 1), and the causal effect
of treatment is estimated to be an increase of 0.6%.
This issue of measurement error in the estimation of gestation age may or may not have
much of a practical impact on the results, but authors who wish to use this identification
strategy should address whether their treatment and control groups are likely to have simi-
larly measured gestation ages.3 This is particularly important when the outcome is defined
in terms of gestation age such as whether the child is born pre-term (defined as being born
prior to 37 weeks of gestation).
4 Conclusion
Estimating the causal effect of in utero conditions on birth and later life outcomes presents
several challenges relating to identification. This comment addresses one identification strat-
egy that has been used several times in the literature, which is to use expected date of birth
to define treatment groups because the actual date of birth may be endogenous. Depending
on the outcome being studied, actual date of birth may not be endogenous. Also since the
expected date of birth is such a strong predictor of actual date of birth, the endogeneity
may make little difference in practice. Researchers can easily address this issue by conduct-
ing a regression based test for endogeneity. The second concern is that gestation age may
be poorly measured in the treatment group in a way which biases the distribution of the
expected birth date in the population. Ultimately, more work is needed on the part of re-
searchers to show that the issue of measurement error in the estimation of gestation age does
not affect the estimates using this identification strategy. I believe that this paper could be
greatly improved if the authors were able to satisfactorily address these concerns.
2The study was limited to spontaneous deliveries, which makes it difficult to compare the post-term
numbers to a sample that includes right censored pregnancies (induced labor and c-sections).
3The treatment need not lead only lead to a greater measurement error in the treatment group. If the
treatment is defined as the presence of a health clinic, as in Rossin-Slater (2013), then the treatment group
may have more accurately measured gestation age.
5
References
Black, S., P. Devereux, and K. Salvanes (2016). Does grief transfer across generations?
bereavements during pregnancy and child outcomes. American Economic Journal: Applied
Economics 8 (1).
Currie, J. and M. Rossin-Slater (2013). Weathering the storm: Hurricanes and birth out-
comes. Journal of Health Economics 32 (3), 487–503.
Persson, P. and M. Rossin-Slater (2016). Family ruptures, stress, and the mental health of
the next generation. American Economic Review forthcoming .
American College of Obstetricians and Gynecologists (2014). Committee opinion no. 611:
Method for estimating due date. Obstetricics and Gynecology 124, 863–866.
Rossin-Slater, M. (2013). Wic in your neighborhood: New evidence on the impacts of
geographic access to clinics. Journal of Public Economics 102 (0), 51–69.
Thagaard, I., L. Krebs, U. Lausten-Thomsen, S. Larsen, J.-C. Holm, M. Christiansen, and
T. Larsen (2016). Dating of pregnancy in first versus second trimester in relation to
post-term birth rate: a cohort study. PLOS ONE 11 (1).
Verburg, B. O., E. A. P. Steegers, M. D. Ridder, R. J. M. Snijders, E. Smith, A. Hofman,
H. A. Moll, V. W. V. Jaddoe, and J. C. M. Witteman (2008). New charts for ultrasound
dating of pregnancy and assessment of fetal growth: longitudinal data from a population-
based cohort study. Ultrasound in Obstetrics & Gynecology 31 (4), 388–396.
6
